Intracellular coccidian protozoan parasites in the genus Sarcocystis.
Humans are the natural definitive host for Sarcocystis hominis, S. heydorni, and S. suihominis, acquired by eating undercooked sarcocyst-containing beef or pork, resulting in intestinal sarcocystosis. Dead-end intermediate host infection can occur in humans with S. nesbitti and possibly other species when food, water, or soil contaminated with the feces from a reptilian sporocyst-shedding definitive host (likely snake) is ingested, resulting in muscular sarcocystosis.
Human intestinal sarcocystosis occurs worldwide, but the prevalence is poorly defined and may vary regionally. Outbreaks of symptomatic muscular sarcocystosis among tourists in Malaysia suggest that intermediate-host infection may be of public health significance. Most reported cases have been acquired in the tropics and subtropics, particularly in Southeast Asia.
Most people with intestinal sarcocystosis are asymptomatic or experience mild gastroenteritis, though severe illness has been described. Differences in symptoms and illness severity and duration may reflect the number and species of the sarcocysts ingested. The disease is thought to be self-limited in immunocompetent hosts.
Intermediate-host infection may range from asymptomatic to severe and debilitating. In those with symptoms, onset occurs in the first 2 weeks after infection, and symptoms typically resolve in weeks to months. However, some patients may remain symptomatic for years. The most common symptoms are fever, fatigue, myalgia, headache, cough, and arthralgia. Less frequent are wheezing, nausea, vomiting, diarrhea, rash, lymphadenopathy, and symptoms reflecting cardiac involvement such as palpitations. Fever and muscle pain may be relapsing and can occur in 2 distinct phases: early (beginning during the second week after infection) and late (beginning during the sixth week after infection). Early-phase disease may reflect a generalized vasculitis, and late-phase disease may coincide with the onset of a diffuse focal myositis.
Intestinal sarcocystosis should be considered in patients with gastroenteritis and a history of eating raw or undercooked meat. Oocysts or sporocysts can be confirmed in stool by light or fluorescence microscopy; PCR is not widely available, and no serologic assays have been validated for use in humans.
Muscular sarcocystosis should be considered in people presenting with myalgia, with or without fever, and a history of travel to a tropical or subtropical region, especially Malaysia. However, diagnosis during the early phase of infection is difficult because of the lack of specificity of symptoms and clinical and laboratory findings. In the absence of an alternative diagnosis, serial investigations for evidence of myositis and eosinophilia should be considered. In those with myositis, trichinellosis should be excluded. Confirmation of muscular sarcocystosis requires biopsy and histologic observation of sarcocysts in muscle. Diagnostic assistance is available through CDC (www.cdc.gov/dpdx; email@example.com).
There are no proven medical treatments for sarcocystosis. Trimethoprim-sulfamethoxazole may have activity against schizonts in the early phase of muscular sarcocystosis, but data are scant. Glucocorticoids and nonsteroidal anti-inflammatories may improve the symptoms associated with myositis.
Intestinal sarcocystosis can be prevented by thoroughly cooking or freezing meat, which kills the infective bradyzoites. Muscular sarcocystosis can be prevented with standard food and water precautions (see Chapter 2, Food & Water Precautions).
Dubey JP, van Wilpe E, Calero-Bernal R, Verma SK, Fayer R. Sarcocystis heydorni, n. sp. (Apicomplexa: Sarcocystidae) with cattle (Bos taurus) and human (Homo sapiens) cycle. Parasitol Res. 2015 Nov;114(11):4143–7.
Esposito DH, Stich A, Epelboin L, Malvy D, Han PV, Bottieau E, et al. Acute muscular sarcocystosis: an international investigation among ill travelers returning from Tioman Island, Malaysia, 2011–2012. Clin Infect Dis. 2014 Nov 15;59(10):1401–10.
Fayer R, Esposito DH, Dubey JP. Human infections with Sarcocystis species. Clin Microbiol Rev. 2015 Apr;28(2):295–311.
Italiano CM, Wong KT, AbuBakar S, Lau YL, Ramli N, Syed Omar SF, et al. Sarcocystis nesbitti causes acute, relapsing febrile myositis with a high attack rate: description of a large outbreak of muscular sarcocystosis in Pangkor Island, Malaysia, 2012. PLoS Negl Trop Dis. 2014 May;8(5):e2876.
Slesak G, Schafer J, Langeheinecke A, Tappe D. Prolonged clinical course of muscular sarcocystosis and effectiveness of cotrimoxazole among travelers to Tioman Island, Malaysia, 2011–2014. Clin Infect Dis. 2015 Jan 15;60(2):329.
Tappe D, Stich A, Langeheinecke A, von Sonnenburg F, Muntau B, Schafer J, et al. Suspected new wave of muscular sarcocystosis in travellers returning from Tioman Island, Malaysia, May 2014. Euro Surveill. 2014;19(21):pii=20816. https://doi.org/10.2807/1560-7917.ES2014.19.21.20816.
Wassermann M, Raisch L, Lyons JA, Natusch DJD, Richter S, Wirth M, et al. Examination of Sarcocystis spp. of giant snakes from Australia and Southeast Asia confirms presence of a known pathogen—Sarcocystis nesbitti. PLoS One. 2017 Nov 13;12(11):e0187984.
We take your privacy seriously. You can review and change the way we collect information below.
These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.
Cookies used to make website functionality more relevant to you. These cookies perform functions like remembering presentation options or choices and, in some cases, delivery of web content that based on self-identified area of interests.
Cookies used to track the effectiveness of CDC public health campaigns through clickthrough data.
Cookies used to enable you to share pages and content that you find interesting on CDC.gov through third party social networking and other websites. These cookies may also be used for advertising purposes by these third parties.